<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Unified all-atom molecule generation with neural fields - Health AI Hub</title>
    <meta name="description" content="FuncBind introduces a novel computer vision-based framework that utilizes neural fields and score-based generative models to achieve unified, target-conditioned">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Unified all-atom molecule generation with neural fields</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.15906v1" target="_blank">2511.15906v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-19
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Matthieu Kirchmeyer, Pedro O. Pinheiro, Emma Willett, Karolis Martinkus, Joseph Kleinhenz, Emily K. Makowski, Andrew M. Watkins, Vladimir Gligorijevic, Richard Bonneau, Saeed Saremi
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.LG, q-bio.BM
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.15906v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.15906v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">FuncBind introduces a novel computer vision-based framework that utilizes neural fields and score-based generative models to achieve unified, target-conditioned, all-atom molecule generation across diverse atomic systems. This modality-agnostic approach overcomes limitations of existing models by effectively generating small molecules, macrocyclic peptides, and antibody CDR loops, validated by competitive in silico performance and successful in vitro generation of novel antibody binders.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>FuncBind offers a significant advancement in structure-based drug design by enabling the unified, de novo generation of diverse therapeutic molecules‚Äîfrom small molecules to complex biologics like antibodies‚Äîconditioned on specific biological targets, thereby accelerating the discovery and optimization of new treatments.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The AI application is the generative design of novel therapeutic molecules (small molecules, peptides, and antibodies) conditioned on target structures. This accelerates and enhances the early stages of drug discovery by autonomously proposing molecular structures with desired binding properties, potentially leading to new treatments for diseases.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>**Modality-Agnostic Generation**: FuncBind unifies all-atom molecule generation across diverse atomic systems (small to large molecules, variable atom/residue counts, non-canonical amino acids) using a single, unified model.</li>
                    
                    <li>**Neural Field Representation**: Molecules are represented as continuous atomic densities using neural fields, offering a flexible and continuous molecular description.</li>
                    
                    <li>**Score-Based Generative Models**: The framework employs score-based generative models, leveraging modern architectures adapted from computer vision literature.</li>
                    
                    <li>**Target-Conditioned Design**: It enables the generation of molecules specifically conditioned on target structures, crucial for structure-based drug design applications.</li>
                    
                    <li>**Competitive In Silico Performance**: Achieves strong performance in generating small molecules, macrocyclic peptides, and antibody complementarity-determining region (CDR) loops.</li>
                    
                    <li>**In Vitro Validation**: Successfully generated novel antibody binders in vitro through de novo redesign of the CDR H3 loop from existing co-crystal structures.</li>
                    
                    <li>**New Dataset and Benchmark**: Introduces a new dataset and benchmark specifically for structure-conditioned macrocyclic peptide generation.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>FuncBind utilizes neural fields to represent molecules as continuous atomic densities. It employs score-based generative models, leveraging modern architectures adapted from computer vision, to perform target-conditioned, all-atom molecule generation. This representation allows for a unified, modality-agnostic approach capable of handling diverse atomic systems and variable atom/residue counts.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The framework achieved competitive in silico performance in generating small molecules, macrocyclic peptides, and antibody complementarity-determining region (CDR) loops, all conditioned on specific target structures. Crucially, FuncBind successfully generated novel antibody binders through in vitro experimentation by de novo redesigning the H3 loop of two selected co-crystal structures. A new dataset and benchmark for structure-conditioned macrocyclic peptide generation were also introduced.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This technology has the potential to revolutionize drug discovery and therapeutic development by significantly accelerating the design cycle for novel small molecules, peptides, and antibody-based biologics. Its ability to generate target-specific binders could lead to more effective and precisely tailored treatments for a wide range of diseases, potentially enabling faster responses to emerging health crises and facilitating personalized medicine approaches.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations or caveats of the FuncBind framework.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly outline specific future research directions, beyond the contributions presented within the paper itself.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Drug Discovery</span>
                    
                    <span class="tag">Immunology</span>
                    
                    <span class="tag">Biologics Development</span>
                    
                    <span class="tag">Structural Biology</span>
                    
                    <span class="tag">Pharmacology</span>
                    
                    <span class="tag">Protein Engineering</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Generative Models</span>
                    
                    <span class="tag tag-keyword">Neural Fields</span>
                    
                    <span class="tag tag-keyword">Score-based Models</span>
                    
                    <span class="tag tag-keyword">Drug Design</span>
                    
                    <span class="tag tag-keyword">Antibody Design</span>
                    
                    <span class="tag tag-keyword">Macrocyclic Peptides</span>
                    
                    <span class="tag tag-keyword">Structure-based Design</span>
                    
                    <span class="tag tag-keyword">Therapeutics</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Generative models for structure-based drug design are often limited to a specific modality, restricting their broader applicability. To address this challenge, we introduce FuncBind, a framework based on computer vision to generate target-conditioned, all-atom molecules across atomic systems. FuncBind uses neural fields to represent molecules as continuous atomic densities and employs score-based generative models with modern architectures adapted from the computer vision literature. This modality-agnostic representation allows a single unified model to be trained on diverse atomic systems, from small to large molecules, and handle variable atom/residue counts, including non-canonical amino acids. FuncBind achieves competitive in silico performance in generating small molecules, macrocyclic peptides, and antibody complementarity-determining region loops, conditioned on target structures. FuncBind also generated in vitro novel antibody binders via de novo redesign of the complementarity-determining region H3 loop of two chosen co-crystal structures. As a final contribution, we introduce a new dataset and benchmark for structure-conditioned macrocyclic peptide generation. The code is available at https://github.com/prescient-design/funcbind.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>NeurIPS 2025</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>